StonvexLoading…
StonvexStonvexStonvexCore line items from CNC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $48.09B | $44.66B | $174.58B | $129.85B | $84.96B |
Operating Income | Not available | $1.86B | $-7.62B | $-5.88B | $1.08B |
Net Income | Not available | $1.54B | $-6.67B | $-5.57B | $1.06B |
EPS (Diluted) | $1.07 | $3.11 | $-13.53 | $-11.29 | $2.13 |
Total Assets | Not available | $81.17B | $76.75B | $82.09B | $86.39B |
Total Liabilities | Not available | $59.65B | $56.69B | $61.03B | $58.89B |
Cash & Equivalents | Not available | $21.26B | $17.89B | $17.06B | $14.51B |
Free Cash Flow OCF − CapEx | Not available | $4.17B | $4.32B | $4.10B | $2.95B |
Shares Outstanding | Not available | 493.77M | 491.76M | 491.41M | 491.13M |